convalescent

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, and circulating variants have rendered…

The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health that show plasma from patients…

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma -- a blood product collected from patients recovered from infections with the coronavirus (SARS-CoV-2) that…

Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study shows. The treatment, known as convalescent…

COVID-19 convalescent plasma showed a likely benefit for patients early in the pandemic before remdesivir and corticosteroids were in use, according to results of a landmark study published today in JAMA Internal Medicine that included…

Blood collection specialist Kathryn Severson holds a bag of convalescent plasma from a recovered coronavirus patient at the Central Seattle Donor Center of Bloodworks Northwest during the coronavirus disease (COVID-19) global outbreak, in…

Early in the pandemic, scientists thought convalescent plasma might be a way to treat COVID-19. the plasma of people who had recovered (or convalesced) from COVID-19, the idea was this antibody-rich infusion would help their immune systems…

In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from recovered patients and give it to the sick. The hypothesis was that components in the so-called "convalescent plasma"…

The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when…